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Coronavirus Transmission In the Dental Setting 
Oral health professionals should remain up-to-date on the coronavirus, and clinical 
measures to prevent its transmission in the dental setting. 
By Susan H. Davide, RDH, MS, MSEd, Anty Lam, RDH, MPH and Christine Macarelli, RDH, MS 
On Apr 17, 2020 
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This course was published in the April 2020 issue and expires April 2023. The authors have no 
commercial conflicts of interest to disclose. This 2 credit hour self-study activity is electronically 
mediated. 
EDUCATIONAL OBJECTIVES 
After reading this course, the participant should be able to: 
l. Describe the nature of coronaviruses, the types of illnesses they cause, and routes of 
transmission. 
2. Discuss the estimated incubation period for 2019 novel coronavirus (COVID-79). and risk 
factors for various patient populations. 
3. Explain appropriate clinical responses to the COVID-19 pandemic, and what oral health 
professionals can do to prevent its spread in the dental setting. 
INTRODUCTION 
The 2079 novel coronavirus, which manifests as COVID-19, is described as the defining global 
health crisis of our time. The most recent disease to be classif ied by the World Health 
Organization as a pandemic, COVID-19 joins cholera, bubonic plague, smallpox and influenza as 
among the most brutal killers in history. As researchers work to develop pharmaceutical 
interventions for COVID-19, valiant efforts are being made worldwide to prevent or reduce 
transmission. Health care professionals are facing unprecedented circumstances related to 
patient care and growing concern about this deadly disease; for example, the American Dental 
Association recommends that dental practices nationwide postpone elective procedures to 
slow its spread. 
This article reviews the emergence, transmission pathways and symptoms of COVID-19, and also 
provides clinical strategies to help mitigate the pandemic. As a dental professional and 
educator, I am confident this article will guide dental teams in complying with best practices 
and providing care in accordance with U.S. Centers for Disease Control and Prevention 
guidelines, ultimately protecting patients, staff and the community at large. 
-Leann Keefer, ROH, BSEd, MSM 
Director, Clinical Services 
Crosstex International 
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In late 2019, an outbreak of atypical pneumonia of 
unknown cause presented in Wuhan in China's 
Hubei Province. Upon investigation, the confirmed 
cases were linked to a Wuhan market where wild 
animals, including marmots, birds, rabbits, bats and 
snakes, were being traded illegally. On December 31, 
2019, the World Health Organization (WHO) was 
notified of this outbreak by authorities in China. 
Virological testing disclosed a novel coronavirus in 
these patients, and, within a few weeks, WHO 
tentatively named it as 2019 novel coronavirus (2019-
2 
nCoV). 
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On February 11, 2020, the International Committee on 
Taxonomy of Viruses announced the new name of the virus as severe acute respiratory 
3 
syndrome coronavirus, or SARS-CoV-2. This was chosen due to the virus being genetically 
3 
related to the coronavirus responsible for the SARS outbreak in 2003. On the same day, WHO 
named the new disease COVID-19, following guidelines previously developed with the World 
3 
Organization for Animal Health and Food and Agricultural Organization of the United Nations. 
Regardless of the nomenclature, this fast-spreading disease poses a global health risk. 
Consequently, dental teams should remain up-to-date on its presentation, and clinical 
measures to prevent its transmission in the dental setting. 
Coronaviruses (CoV) are a large family of viruses that cause illness ranging from respiratory 
infections (including the common cold to flu-like or pneumonia symptoms), as well as 
4 
gastrointestinal symptoms - all which may or may not appear and range in severity. Middle 
4 
East respiratory syndrome (MERS-CoV) and SARS-CoV outbreaks continue to occur globally. A 
novel coronavirus (nCoV) is a new strain that has not been previously identified in humans, and 
is considered a zoonotic disease that spreads from animals to humans. Further investigations 
determined the source of SARS-CoV transmission was from civet cats to humans and MERS-
CoV from dromedary camels to humans. Although the specific source of COVID-19 has not 
been identified, bats and pangolins are currently implicated. As a novel coronavirus, the 
information scientists have gathered about it may change as researchers and the medical 
5 
community continue to learn how the virus behaves. 
The U.S. Centers for Disease Control and Prevention (CDC) reinforced the need for clinicians to 
be watchful for exposure to COVID-19, not only with patients who are returning travelers from 
areas with high incidence of the disease, but also with individuals who have come in contact 
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TRANSMISSION 
Cases of COVID-19 continue to spread globally. As of April 9, 2020, more than 1.5 million cases 
78 
had been reported worldwide, with 89,877 deaths. ' The disease has spread via travel from 
8 
China to at least 177 countries, with evidence of sustained transmission on six continents. As of 
April 9, 2020, the United States had more than 395,000 confirmed cases across all 50 states, with 
12,754 deaths. 
7,9,10 
Chinese officials confirmed the COVID-19 outbreak was associated with the Huanan Seafood 
11 
Market, a "wet market" in Wuhan. Wet markets sell live fish and animals, and have a history of 
transmitting viruses. Typically, purchases are immediately slaughtered on site, which can cause 
particles of infectious bacteria or viruses to become aerosolized and transmit from animals to 
11 
people. Investigators suspect that someone purchased contaminated meat, became sick 
12 
before or after consuming it, and spread the infection to others. Though the virus can spread 
by consuming infected animals, it can also spread through coughing, sneezing and close 
12 
contact with an infected person or an object carrying the virus. 
According to CDC officials, it may be possible to contract COVID-19 by touching a surface or 
object that has the virus on it and then touching the mouth, nose or possibly eyes, but this is 
12 
not a confirmed primary mode of transmission. With most respiratory viruses, people are 
12 
typically considered most contagious when they present with acute symptoms. Presently, it is 
not clear how contagious those infected with the virus are during the incubation period; 
however, there have been reports of transmission in individuals who show no signs or 
13 
symptoms of the disease. 
SIGNS, SYMPTOMS AND PREVENTION 
Signs and symptoms of COVID-19 are similar to other respiratory illnesses, and can include 
runny nose, sore throat, fever, cough, shortness of breath, and breathing difficulties. In more 
advanced cases, infections can lead to pneumonia, severe acute respiratory syndrome, kidney 
414 
failure and death. · Because the symptoms of the coronavirus are similar to that of other 
common respiratory infections (such as a cold or flu), a definitive diagnosis can only be made 
4,14 
with a laboratory test. 
15 
The severity of symptoms in confirmed cases has ranged from no or mild symptoms to severe. 
The incubation period - as reported by the CDC at presstime - is between two to 14 days from 
15 
exposure to the occurrence of disease signs and symptoms. By comparison, WHO estimates 
14 
that incubation ranges between one and 12.5 days, with a median of five to six days. The 
estimates for the incubation period for COVID-19 are based on previous observations with other 
14,15 
coronavirus diseases, such as SARS and MERS. 
This website uses cookies to improve your experience. We'll assume you're ok with this, but 
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The elderly and individuals who present with preexisting medical conditions, such as heart 
disease, high blood pressure, cancer, diabetes or lung conditions, seem to experience more 
15 
serious complications. At this time, there is no research regarding the susceptibility of 
76 
pregnant women to the virus, and no evidence to suggest children are at increased risk. 
On January 30, 2020, WHO classified the rapidly spreading outbreak as a Public Health 
5,17 
Emergency of International Concern, and on March 11 WHO declared it a pandemic. In 
response to the outbreak, the CDC has partnered with health officials and health care systems 
to reduce the impact of the virus and reinforce infection prevention principles. The CDC is using 
a 2077 Morbidity and Mortality Weekly Report as a blueprint for community interventions and 
1819 
adapting it to COVID-19. · With no vaccine available to prevent coronavirus disease, the CDC 
recommends everyday preventive actions to halt the spread of respiratory diseases, including 
20 
COVID-19 {Table 7). 
TABLE 1. Everyday Actions to Prevent the Spread of 
Respiratory Diseases20 
• Wash your hands often with soap and water for at least 20 seconds, 
especially after going to the bathroom, before eating, and after blowing your 
nose, coughing or sneezing. 
• If soap and water are not readily available, use an alcohol-based hand sanitizer 
with at least 60% alcohol. Always wash hands with soap and water if hands are 
visibly dirty. 
• Avoid close contact with people who are sick. 
• Avoid touching your eyes, nose and mouth. 
• Stay home when you are sick. 
• Cover your mouth with a t issue when you sneeze and throw the tissue in the 
trash. 
• Clean and disinfe ct frequently touched objects and surfaces using regular 
household cleaning sprays or wipes. 
• In response to COVID-19, the U.S. Centers for Disease Control and Prevention 
suggests that all individuals should wear cloth face coverings when out in public. 
• People who show symptoms of COVID-19 should use face masks to help 
prevent the spread of the disease. 
• The use of face masks is crucial for health care workers and individuals who are 
taking care of someone in close settings (at home or in a health care facility). 
RESOURCES FOR CLINICIANS 
The CDC maintains a comprehensive site for health care professionals that includes 
preparedness resources to assist providers, clinics and hospitals when managing patients with 
��W�b�ft�0Sl¥s�t'6�tt?iro0f �Bld&e 7Ja1?istpi1rtFisc�W�fl �l!'D�Q3/c5t59r�51��rR�f.Yis� 'b'6t 
assess patients who may be ill with, or who may have been exposed to the disease. 
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The CDC also offers a clinical criteria form to guide evaluation for individuals under investigation 
22 
for COVID-19 based on what is known about MERS-CoV and SARS-CoV. In the event a person 
under investigation for COVID-19 presents in dental practice, clinicians should immediately 
notify the appropriate infection prevention personnel at their health care facility, as well as local 
22 
and state health departments. 
The American Dental Association (ADA) and American Dental Hygienists' Association have 
23, 24 
issued statements and provided resources related to COVID-19. As of presstime, each 
organization also recommends that oral health professionals postpone elective and 
nonemergency procedures , but remain available for dental emergencies that are considered 
2324 
"potentially life threatening," according to the ADA. · Once active practice resumes, it will be 
more important than ever for dental settings to follow standard precautions and infection 
control, as outlined in the CDC's Guidelines for Infection Control in Dental Health-Care Settings 
25 
-2003. 








Questions to Ask Patient Recommendations 
• Have you traveled outside of the coun� or within a geographical area 
that has a high incidence of COVID-19 In the last 14 days? 
• Have you been in dose contact with anyone who has traveled outside 
the country or within a geographical area that has high incidences of 
COVID-19 in the last 14 days? 
• Do you have a cold or any respiratory issues? 
• Do you have a fever or have you had a fever within the last 14 days? 
• Do you have a sore throat? 
• Same questions as above rf not able to interview patient prior to the 
dental visft 
• If the patient exhibits signs and symptoms during care (e.g., respiratory 
symptoms, cough, runny nose or feverish). diniaans should: 
• If "yes" to any one of these questions, 
postpone patient care 
• Advise patient to seek medical attention 
(if he/she has not already done so) 
• Instruct patient to reschedule when free 
from signs/symptoms of ailment 
• Same as above 
• Stop patient care 
• Advise patient to seek medical attention 
• Instruct patient to reschedule when free 
from signs/ symptoms of ailment 
Dental health care personnel (DHCP) who are in contact with patients, and whose 
responsibilities include cleaning and disinfecting, handling contaminated supplies or 
equipment, and who work in proximity to potentially contaminated surfaces, should diligently 
20 
follow all infection prevention procedures. To prevent infections from spreading during health 
care delivery, an effective asepsis protocol - including administrative rules, engineering 
controls, environmental hygiene, correct work practices, and appropriate use of personal 
protective equipment (PPE) - is essential. The CDC provides infection control guidance for 
20 
health care settings. These are basic rationale and techniques familiar to DHCP for exposure 
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including SARS, MERS and endemic human coronaviruses, revealed that each can remain on 
surfaces-such as metal, glass or plastic-for up to nine days. Surface disinfectant protocols 
with 62% to 71% ethanol (rubbing) alcohol, 0.5% hydrogen peroxide, or 0.1% sodium hypochlorite 
26 
(bleach) can inactivate the viruses within 60 seconds of contact time. 
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The CDC's Guidelines for Infection Control in Dental Health-Care Settings -2003 discuss the 
use of PPE to prevent potentially infectious splash, spatter and aerosols generated during 
rinsing, or when using hand pieces and other devices (such as ultrasonic units).25 Employers 
should select appropriate PPE and provide it to DHCP in accordance with the Occupational 
27 Safety and Health Administration's PPE standards (29 CFR 1910 Subpart 7). Dental teams must 
receive training and demonstrate an understanding of when to use PPE; what PPE is necessary; 
how to properly don, use and doff PPE to prevent self-contamination; how to properly dispose 
of or disinfect and maintain PPE; and the limitations of protective equipment (Table 4).28'29 
Er�rist��@le§� � lfl:89��  �'Ffe1ri>ch:J �cf r£§>e ffie1�Wrele'R=%i�A1�i� but 
worn during procedures that involve possible aerosols, splash or spatter. According to the U.S. 
Food and Drug Admi��Wa1filh?Jli.ft�fd�iY/3�e'm£;k tb<v9rls\h�'J1g� and mouth, and is 
labeled as a surgical, laser, isolation, dental or medical procedure mask (with or without a face 
30 
shield). There are multiple levels of mask protection for DHCP, each identified according to 
bacterial filtration and particulate filtration efficiency levels that correspond to the demands of 
28 
a given dental procedure. Health care and institutional settings use respirators that are at 
least as protective as an N95 respirator before entry into the patient care area. Oral health 
professionals working in facilities with high infectious disease transmission potential, such as 
hospitals, long-term care facilities, and dental care units located in these type of settings, may 
warrant use of an N95 respirator. 
TABLE 4 .  Persona l Protect ive Equ i pment 
Gloves 
• Perform hand hygiene, then put on c lean ,  non-ster i le g loves pr ior to patient care . 
C hange g loves if they become torn or heavi ly contam i nated .  
• Remove and d i scard g loves when patient ca re i s  completed ,  and immed iately 
perform hand hyg iene .  
Face Mask Protection28 
Level 1 masks p rovi de a protect ion va lue  of 2: 95% bacteri a l  fi ltrat ion efficiency 
(B FE) and particu late fi ltrat ion eff iciency (PFE); these are su itable for br ief 
exam i nations, exposi n g  rad iographs a nd  c lean ing tasks .  
Level 2 masks offer a moderate protection of 2: 98% BFE and PFE, and are 
preferab le  fo r procedures that i nvolve a moderate leve l of aerosols, such as hand 
instrumentation or app lyi ng sea lants . 
Leve l 3 masks offer a h igh level of protect ion of 2: 98% BFE a nd PFE, and a re used 
for procedu res i nvo lvi ng h igh  leve ls of aerosols , such as u l trasonic sca l i n g, su rg ica l  
procedu res and crown prepa ration . 
Maximum fi ltrat ion masks, such as a n  N95 particu late respi rator, feature 99 . 9% 
PFE and  are ind icated when t reat ing patients with a i rborne d iseases . 
Eye Protection 
• Wear eye protection (e. g . ,  safety g lasses or a d isposab le face sh ie ld that covers 
the front and s ides of the face) u pon entry to the patient care a rea . 
• Remove eye protection before leaving the patient care area . 
• Reusab le  eye p rotect ion (e . g . , safety g lasses) must be cleaned and dis infected 
accord ing to manufactu rer's reprocessi ng i nstructions prior to reuse . 
• D isposable eye protection shou ld  be d iscarded after use .  
• Denta l lou pes must be  c leaned and  d is infected between each patient to avoid 
cross-contami nat ion r isks . 29  
SU M MARY 
All health care personnel need to be prepared for, and remain informed about, COVID-79, its 
�W��it�e��c�RfR��ta� r&f&/@'yB'tfr �ent:� wg,iffl ��t:lftlfe �a0¥e1�RiW"ltR£�is , but 
health professionals have a responsibility to be knowledgeable about infectious diseases. 
Providers should also �� �� RRft:8Yt�fs¥8H?��n�'i<tfmf cli��to the highest 
standards of infection control. B y  maintaining a standard of care that is in accordance with CDC 
guidelines, dental teams can effectively contribute to disease prevention and help slow the 
coronavirus pandemic. 
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